These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6623888)

  • 41. [Effects of a new non-steroid anti-inflammatory agent (Voltaren) on blood platelets and erythrocytes with (G-6-PD) enzyme deficiency. Preliminary notes].
    Palmas S; Sana A; Onorato D
    Reumatismo; 1977; 29(2-3):180-3. PubMed ID: 616965
    [No Abstract]   [Full Text] [Related]  

  • 42. Tolmetin and G-6-PD erythrocyte deficiency: research in vitro.
    Passiu G; Piras MG; Perpignano G; Ibba G; Carcassi U
    J Int Med Res; 1979; 7(5):351-3. PubMed ID: 499642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes.
    Bocci V; Luzzi E; Corradeschi F; Paulesu L; Rossi R; Cardaioli E; Di Simplicio P
    J Biol Regul Homeost Agents; 1993; 7(4):133-8. PubMed ID: 8023701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variation of erythrocyte glutathione peroxidase activity in Finn sheep.
    Atroshi F; Sankari S; Osterberg S; Sandholm M
    Res Vet Sci; 1981 Nov; 31(3):267-71. PubMed ID: 7342221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of vitamin K1 on glucose-6-phosphate dehydrogenase deficient neonatal erythrocytes in vitro.
    Kaplan M; Waisman D; Mazor D; Hammerman C; Bader D; Abrahamov A; Meyerstein N
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F218-20. PubMed ID: 10194997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of ascorbic acid on copper-induced oxidative changes in the erythrocytes of rats, sheep, and normal humans.
    Calabrese EJ; Moore GS; McCarthy MS
    Regul Toxicol Pharmacol; 1983 Sep; 3(3):179-83. PubMed ID: 6635265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low glucose-6-phosphate dehydrogenase (G-6-PD) activity in red blood cells and susceptibility to copper-induced oxidative damage.
    Calabrese EJ; Moore GS; Ho SC
    Environ Res; 1980 Apr; 21(2):366-72. PubMed ID: 7408807
    [No Abstract]   [Full Text] [Related]  

  • 48. Band 3 tyr-phosphorylation in normal and glucose-6-phospate dehydrogenase-deficient human erythrocytes.
    Bordin L; Zen F; Ion-Popa F; Barbetta M; Baggio B; Clari G
    Mol Membr Biol; 2005; 22(5):411-20. PubMed ID: 16308275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age.
    Oztürk O; Gümüşlü S
    Exp Gerontol; 2004 Feb; 39(2):211-6. PubMed ID: 15036414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G-6-PD variants in Chinese in Thailand.
    Panich V; Na-Nakorn S; Wasi P
    Southeast Asian J Trop Med Public Health; 1980 Jun; 11(2):250-5. PubMed ID: 7434076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of glucose-6-phosphate dehydrogenase deficiency in Nigerian patients with sickle cell disease.
    Ahmed SG; Ibrahim UA
    Niger Postgrad Med J; 2002 Dec; 9(4):181-5. PubMed ID: 12690675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hemotoxicity of para-substituted aniline analogs in dog and rat erythrocytes: a species comparison.
    Purnell ET; Singh H
    Ethn Dis; 2005; 15(4 Suppl 5):S5-81-7. PubMed ID: 16315385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs.
    Fraser IM; Tilton BE; Vesell ES
    Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diminished activity of the hepatic glucuronation of the salicylamide in subjects with erythrocyte deficiency of glucosephosphate dehydrogenase (G-6-PD)].
    Cutillo S
    Pediatria (Napoli); 1975 Sep; 83(3):vi-vii. PubMed ID: 1223739
    [No Abstract]   [Full Text] [Related]  

  • 55. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.
    Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS
    Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of pyrimidine 5'nucleotidase activity in erythrocytes of sheep, dogs, cats, horses, calves, and Mongolian gerbils.
    George JW; Duncan JR; Mahaffey EA
    Am J Vet Res; 1983 Oct; 44(10):1968-70. PubMed ID: 6314858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.
    Fraser IM; Vesell ES
    Ann N Y Acad Sci; 1968 Jul; 151(2):777-94. PubMed ID: 4391843
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of protein -SH groups in redox homeostasis--the erythrocyte as a model system.
    Di Simplicio P; Cacace MG; Lusini L; Giannerini F; Giustarini D; Rossi R
    Arch Biochem Biophys; 1998 Jul; 355(2):145-52. PubMed ID: 9675020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of formate on GSH concentration and Heinz body formation: a preliminary model study.
    Rapoport S; Müller M; Siems W; Grieger M
    Haematologia (Budap); 1974; 8(1-4):127-34. PubMed ID: 4142616
    [No Abstract]   [Full Text] [Related]  

  • 60. G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
    Moore GS; Calabrese EJ
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):271-9. PubMed ID: 7462905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.